This opportunity is no longer accepting applications.
grant PAR-23-055

Co-infection and Cancer (R01 Clinical Trial Not Allowed)

This grant aims to improve our understanding of how infections contribute to cancer, particularly focusing on co-infections and their roles in cancer development. The priority is on funding research involving co-infections (excluding HIV) that offer new possibilities for cancer prevention and treatment, especially in less-studied populations. Co-infections refer to situations where two or more…

This initiative seeks to enhance our mechanistic and epidemiologic understanding of infection-related cancers, with a focus on the etiologic roles of co-infection in cancer. Preference will be given to co-infections (excluding co-infection with human immunodeficiency virus [HIV]) that engendered…

Funding Source

Agency: National Institutes of Health
Program: SBIR

Dates

Opportunity Released: December 14, 2022
Open for Submission: December 14, 2022
Submission Deadline: November 5, 2025
Application Window Closes: November 5, 2025

Documents

Secure Grant Funding 10x Faster

Scout delivers AI-powered grant writing paired with experts that's faster, more affordable, and built to win.

Already have an account? Sign In

Trusted by 500+ Happy Customers

Get opportunities sent to your inbox

The latest grant news and insights from our experts.

Save this opportunity and explore more

Share Opportunity

Share this opportunity with others.
Anyone with this link can view the opportunity details.